Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.

about

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B

P2860

Q57952724-01F00112-ECC0-40BE-9F39-4D538425CBE9 Q58701149-D89A69F9-6966-4AE3-9B6D-42042C701D90

P2860

Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.

Item

http://www.wikidata.org/entity/Q51771412

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@en

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@nl

type

Item

label

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@en

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@nl

prefLabel

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@en

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@nl

P1476

Relation between Skin Pharmaco ...... urine Cutaneous Leishmaniasis.

@en

P2093

Andy Harris

http://www.w3.org/2001/XMLSchema#string

Gert-Jan Wijnant

http://www.w3.org/2001/XMLSchema#string

Katrien Van Bocxlaer

http://www.w3.org/2001/XMLSchema#string

Simon L Croft

http://www.w3.org/2001/XMLSchema#string

Sudaxshina Murdan

http://www.w3.org/2001/XMLSchema#string

Vanessa Yardley

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.

Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

P31

scholarly article

P356

10.1128/AAC.02009-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29263075

http://www.w3.org/2001/XMLSchema#string

P932

5826151

http://www.w3.org/2001/XMLSchema#string

Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.

about

P2860

P2860

Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932